Back to results
US 2017/0247466 A1Published application
Treatment of lung cancer using an anti-fucosyl-gm1 antibody
AssigneeBristol-Myers Squibb Company
InventorJeffrey R. JACKSON
Life of this patent
Estimating the term…
Abstract
This disclosure provides a method for treating a subject afflicted with a lung cancer, which method comprises administering to the subject a therapeutically effective amount of an antibody or an antigen-binding portion thereof that specifically binds to Fucosyl-GM1.
Claims20
A method for treating a subject afflicted with a lung cancer, comprising administering to the subject a therapeutically effective amount of a monoclonal antibody or an antigen-binding portion thereof that binds specifically to Fucosyl-GM1, wherein the antibody is administered at a dose ranging from 10 to 2000 mg once every 1, 2, 3 or 4 weeks.
Dependencies are inferred from the claim text.